title: Cellular immunoisolation for islet transplantation by a novel dual porosity electrospun membrane.
abstract: Immunoisolation strategies have the potential to impact the treatment of several diseases, such as hemophilia, Parkinson's and endocrine disorders, such as parathryroid disorders and diabetes. The hallmark of these disease states is the amelioration of the disease process by replacement of the deficient protein. Naturally, several cellular therapeutic strategies like genetically modified host cells, stem cells, donor cells, or even complex tissues like pancreatic islets have been investigated. Current evidence suggests that successful strategies must incorporate considerations for local hypoxia, vascularity, and immunoisolation. Additional regulatory concerns also include safe localization of implanted therapeutic cells to allow for monitoring, dose adjustment, or removal when indicated. Local hypoxia and cellular toxicity can be detrimental to the survival of freshly implanted pancreatic islets, leading to a need for a larger initial number of islets or repeated implantation procedures. The lack of adequate donors and the large number of islet equivalents needed to achieve euglycemic states amplify the nature of this problem. We have developed a novel immunoisolation device based on electrospun nylon, primarily for islet transplantation, such that the inner component functions as a cellular barrier while allowing diffusion, whereas the outer component can be optimized for tissue integration and accelerated vascularization. Devices explanted after subcutaneous implantation in wild-type B6 mice after a period of 30 days show vascular elements in the outer layer of the electrospun device. The inner layer when intact functioned as an effective barrier to cellular infiltration. The preimplantation of such a device, with a relatively thin inner barrier membrane, will allow for adequate vascularization and reduce postimplantation hypoxia. This study demonstrates the feasibility of an electrospun isolation device that can be easily assembled, modified by varying the electrospinning parameters, and functionalized with surface-active molecules to accelerate vascularization.
authors.affiliation: Cardiovascular Innovation Insititute, Louisville, Kentucky 40202, USA.
authors.forename: L
authors.initials: L
authors.lastname: Krishnan
authors.forename: L R
authors.initials: LR
authors.lastname: Clayton
authors.forename: E D
authors.initials: ED
authors.lastname: Boland
authors.forename: R M
authors.initials: RM
authors.lastname: Reed
authors.forename: J B
authors.initials: JB
authors.lastname: Hoying
authors.forename: S K
authors.initials: SK
authors.lastname: Williams
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D002469:Cell Separation / Q000295:instrumentation / Q000379:methods*; D055252:Cell-Derived Microparticles; D000860:Hypoxia; D007150:Immunohistochemistry / Q000379:methods; D007328:Insulin / Q000378:metabolism; D016381:Islets of Langerhans Transplantation / Q000295:instrumentation / Q000379:methods*; D008567:Membranes, Artificial; D051379:Mice; D008855:Microscopy, Electron, Scanning / Q000379:methods; D016062:Porosity; D014183:Transplantation, Heterologous / Q000379:methods
chemical_list: D007328:Insulin; D008567:Membranes, Artificial
references.citation: Transplantation. 2003 Jul 27;76(2):290-6
references.pmid: 12883181
references.citation: Diabetes Care. 2003 Apr;26(4):1176-80
references.pmid: 12663593
references.citation: Am J Surg. 1987 May;153(5):501-4
references.pmid: 2953265
references.citation: Biomaterials. 1996 Feb;17(3):257-66
references.pmid: 8745322
references.citation: Biomaterials. 1996 Feb;17(3):277-84
references.pmid: 8745324
references.citation: Clin Sci (Lond). 2006 Jun;110(6):611-25
references.pmid: 16689680
references.citation: Diabetes. 1994 Sep;43(9):1167-70
references.pmid: 8070618
references.citation: Xenotransplantation. 2008 Mar-Apr;15(2):99-101
references.pmid: 18447878
references.citation: J Biomed Mater Res. 1995 Dec;29(12):1517-24
references.pmid: 8600142
references.citation: Ann Surg. 2003 Jun;237(6):741-9; discussion 749-50
references.pmid: 12796569
references.citation: Tissue Eng. 1996 Winter;2(4):289-98
references.pmid: 19877960
references.citation: Diabetes. 2001 Apr;50(4):710-9
references.pmid: 11289033
references.citation: Expert Opin Biol Ther. 2007 Nov;7(11):1627-45
references.pmid: 17961088
references.citation: Diabetes. 2006 Feb;55(2):312-7
references.pmid: 16443762
references.citation: J Biomater Sci Polym Ed. 2005;16(3):381-95
references.pmid: 15850291
references.citation: J Diabetes Sci Technol. 2009 Mar;3(2):297-303
references.pmid: 19746206
references.citation: Adv Drug Deliv Rev. 2004 Sep 22;56(11):1661-73
references.pmid: 15350295
references.citation: Am J Pathol. 1986 May;123(2):220-30
references.pmid: 3706490
references.citation: J Biomed Mater Res. 1998 Jun 15;40(4):586-97
references.pmid: 9599035